Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Naxitamab and Sargramostim for High-Risk Neuroblastoma in Patients with Refractory Bone or Bone Marrow Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy Spain
  • Study on the Safety and Effects of Ocrelizumab for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Italy Poland
  • Study on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Italy The Netherlands Poland
  • Study on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Poland
  • Study of GS-5245 for Treating COVID-19 in Children and Adolescents

    Not recruiting

    4 1 1
    Investigated Drugs:
    Bulgaria Hungary Italy Poland Spain
  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    3 1
    Bulgaria Denmark France Germany Greece Spain
  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Hungary Italy Poland Spain
  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Estonia Finland +14
  • Study on the Effects and Safety of Pantoprazole for Children and Teens with Healed Erosive Esophagitis

    Not recruiting

    2 1
    Belgium Slovakia
  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark France Germany Greece +7